Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.

Abstract: A control means comprises a control segment (3) that is designed for driving an electrically adjustable piece of furniture and a switched-mode power supply unit (2) that supplies power to the control segment (3). The switched-mode power supply unit (2) features a switching regulator component (223) for controlling the switched-mode power supply unit and can be switched into a normal operating mode and into an idle mode. The switched-mode power supply unit (2) is designed for making available a supply voltage for the switching regulator component (223) in a clocked fashion with the aid of a start-up circuit (224) in the idle mode. The switched-mode power supply unit (2) features a power failure detection circuit (230) that is designed for detecting a failure of a line voltage applied to the input side of the switched-mode power supply unit (2) based on a signal within the start-up circuit (224) and for signaling this failure to the control segment (3).

Abstract: In one embodiment, a plug-cable unit includes a plug connector which is equipped to receive a coding plug. A cable is used for connecting to a functional unit to be controlled, in particular of an electromechanically adjustable piece of furniture. A plug module is used for connecting to a control device of the piece of furniture. In one embodiment, a coding plug includes at least two ports for connecting to related contacts of a plug connector of a plug-cable unit, and at least one electronic component having at least one parameter of a functional unit.

Abstract: A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core elements are coated with a pharmaceutically acceptable coating layer to form coated pellets. The core elements or pellets are treated with an anti-static agent and compressed with suitable excipients to form the compressed solid dosage form. Particular anti-static agents are starch, microcrystalline cellulose, kaolin, bentonite, silicates, silicon dioxide, cellulose, stearic acid, sodium stearyl fumarate and glyceryl behenate.

Abstract: A device can be used for detecting a collision of a displaceable furniture part and an obstacle. The device includes a controller for a drive device for the displaceable furniture part, and a sensor having a first sensor range and a second sensor range. A force and/or a relative motion arising between the first and second sensor parts can be detected.

Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.

Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.

Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.

Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.

Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Abstract: In an operating element for a furniture control for controlling an electrically adjustable piece of furniture, the operating element includes a flat sensor module with a plurality of proximity-sensitive sensor surfaces arranged on the sensor module. An operating panel covers the plurality of sensor surfaces. A set of switching surfaces is marked on the operating panel. A control module is designed for detecting an actuation of one of the switching surfaces based on sensor signals delivered by the sensor surfaces and for generating an actuation signal for the furniture control based on a detected actuation. The sensor module and the control module are arranged in a housing of the operating element, wherein the operating panel forms a cover of the housing.

Abstract: Systems and methods for self-adjusting displays are provided. A self-adjusting display may receive a display characteristics shift profile, where the display characteristics shift profile can be generated based on calibration event data collected from a plurality of displays. The display characteristics shift profile can be utilized as an estimate or prediction of a shift in display characteristics the self-adjusting display may experience over time. The self-adjusting display may calculate adjustment factors or curves to compensate for the estimated/predicted shift in display characteristics to lessen or altogether eliminate the need for performing actual calibration on the self-adjusting display.

Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Abstract: A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core elements are coated with a pharmaceutically acceptable coating layer to form coated pellets. The core elements or pellets are treated with an anti-static agent and compressed with suitable excipients to form the compressed solid dosage form. Particular anti-static agents are starch, microcrystalline cellulose, kaolin, bentonite, silicates, silicon dioxide, cellulose, stearic acid, sodium stearyl fumarate and glyceryl behenate.

Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Abstract: A control means comprises a control segment (3) that is designed for driving an electrically adjustable piece of furniture and a switched-mode power supply unit (2) that supplies power to the control segment (3). The switched-mode power supply unit (2) features a switching regulator component (223) for controlling the switched-mode power supply unit and can be switched into a normal operating mode and into an idle mode. The switched-mode power supply unit (2) is designed for making available a supply voltage for the switching regulator component (223) in a clocked fashion with the aid of a start-up circuit (224) in the idle mode. The switched-mode power supply unit (2) features a power failure detection circuit (230) that is designed for detecting a failure of a line voltage applied to the input side of the switched-mode power supply unit (2) based on a signal within the start-up circuit (224) and for signaling this failure to the control segment (3).

Abstract: A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core elements are coated with a pharmaceutically acceptable coating layer to form coated pellets. The core elements or pellets are treated with an anti-static agent and compressed with suitable excipients to form the compressed solid dosage form. Preferred anti static agents are starch, microcrystalline cellulose, kaolin, bentonite, silicates, silicon dioxide, cellulose, stearic acid, sodium stearyl fumarate and glyceryl behenate.

Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.

Abstract: The invention relates to a device for detecting a collision of a displaceable furniture part and an obstacle, comprising a controller (5) for a drive device for the displaceable furniture part, and a sensor (20) having a first sensor range (21) and a second sensor range (22), wherein a force and/or a relative motion arising between the first and second sensor parts (21, 22) can be detected.